← FDA Drug Approvals (Drugs@FDA)

ASTEPRO

NDA · New Drug Application · Sponsor: VIATRIS · Approved 2008-10-15

Drug application

FDA Application #

NDA022203

Application type

New Drug Application

Brand name

ASTEPRO

Generic name

Azelastine Hydrochloride

Active ingredients

AZELASTINE HYDROCHLORIDE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Discontinued

Sponsor

VIATRIS

First approval

2008-10-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown